clopidogrel has been researched along with Left Ventricular Dysfunction in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, A; Davis, BH; Dillon, C; Limdi, NA; Pamboukian, SV; Williams Iii, LA | 1 |
Di Luozzo, M; Di Roma, M; Lanzillo, C; Lioy, E; Maresca, L; Minati, M; Patrizi, R; Pendenza, G; Preziosi, P; Romagnoli, E; Romeo, F; Sciahbasi, A; Summaria, F | 1 |
Ballesteros Ortega, D; Blancas Gómez-Casero, R; Castro Gallego, O; Chana García, M; Estébanez Montiel, B; López Matamala, B; Marina Martínez, L; Martín Parra, C; Martínez González, O; Prieto Valderrey, F; Quintana Díaz, M; Vigil Escribano, D | 1 |
Doktorova, M; Motovska, Z; Ondrakova, M; Widimsky, P | 1 |
Connolly, SJ; Hart, RG; Healey, JS; Hohnloser, SH; McAlister, FA; Pfeffer, MA; Sandhu, RK; Yuan, F; Yusuf, S | 1 |
Kirsch, ME; Loisance, D; Nakashima, K; Rosanval, O; Vermes, E | 1 |
Ahmad, M; Eikelboom, JW; Natarajan, MK; Salehian, O; Schwalm, JD | 1 |
Delhaye, C; Lemesle, G | 1 |
Abegunewardene, N; Gori, T; Horstick, G; Kreitner, KF; Lehr, HA; Münzel, T; Schmidt, KH; Schreiber, LM; Vosseler, M | 1 |
Al Faleh, H; Al Saif, S; Al Suwaidi, J; Al-Lawati, J; Al-Motarreb, A; Al-Sagheer, NQ; AlHabib, KF; Almahmeed, W; AlQahtani, A; Alsheikh-Ali, AA; Amin, H; Asaad, N; El-Menyar, A; Hersi, A; Singh, R; Sulaiman, K | 1 |
Fabiszak, T; Gierach, J; Kozinski, M; Kubica, A; Kubica, J; Magielski, P; Navarese, EP; Odrowaz-Sypniewska, G; Sukiennik, A; Swiatkiewicz, I | 1 |
Davutoglu, V; Sezen, Y; Soydinc, S | 1 |
Gitt, AK; Gottwik, M; Heer, T; Juenger, C; Schiele, R; Senges, J; Vogel, C; Wienbergen, H | 1 |
Goldberg, SL | 1 |
Cheneau, E; Corso, P; Haile, E; Kapetanakis, EI; Kent, KM; Kuchulakanti, P; Lew, R; Pakala, R; Pichard, AD; Rha, SW; Satler, LF; Suddath, WO; Waksman, R | 1 |
Fonarow, GC; Horwich, TB | 1 |
2 review(s) available for clopidogrel and Left Ventricular Dysfunction
Article | Year |
---|---|
[Decreasing incidence of stent thrombosis].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; Risk Factors; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |
Prevention of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Disease Progression; Health Behavior; Heart Failure; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Prevalence; Renal Insufficiency; Risk Factors; Smoking; Ticlopidine; Ventricular Dysfunction, Left | 2002 |
2 trial(s) available for clopidogrel and Left Ventricular Dysfunction
Article | Year |
---|---|
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Female; Heart Failure; Humans; Irbesartan; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Tetrazoles; Thromboembolism; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Embolism; Feasibility Studies; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Ontario; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left; Warfarin | 2010 |
12 other study(ies) available for clopidogrel and Left Ventricular Dysfunction
Article | Year |
---|---|
Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y
Topics: Adult; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Ventricular Dysfunction, Left | 2019 |
Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Echocardiography; Female; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Stroke Volume; Thrombosis; Ticlopidine; Ventricular Dysfunction, Left; Warfarin | 2013 |
[Influence of the combination of antiplatelet agents on the occurrence of early left ventricular insufficiency in patients with acute coronary syndromes without persistent ST-segment elevation].
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Left | 2014 |
Severe left ventricular systolic dysfunction is independently associated with high on-clopidogrel platelet reactivity.
Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Humans; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Stroke Volume; Ticlopidine; Ventricular Dysfunction, Left | 2014 |
Off-pump replacement of the INCOR implantable axial-flow pump.
Topics: Anticoagulants; Aspirin; Clopidogrel; Equipment Design; Heart-Assist Devices; Humans; Infusion Pumps, Implantable; International Normalized Ratio; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left; Warfarin | 2009 |
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure.
Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Contrast Media; Coronary Angiography; Coronary Stenosis; Disease Models, Animal; Drug Carriers; Female; Fibrosis; Gadolinium; Genes, Reporter; Genes, Synthetic; Genetic Therapy; Heart Failure; Liposomes; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Ischemia; Nitric Oxide Synthase Type II; Random Allocation; Stents; Sus scrofa; Swine; Ticlopidine; Ventricular Dysfunction, Left | 2011 |
Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Female; Heparin; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Ventricular Dysfunction, Left | 2012 |
Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.
Topics: Clopidogrel; Drug Resistance; Electrocardiography; Female; Humans; Middle Aged; Thrombolytic Therapy; Thrombosis; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry).
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Coronary Disease; Coronary Vessels; Drug Utilization; Electrocardiography; Female; Germany; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multivariate Analysis; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Registries; Stroke Volume; Ticlopidine; Ventricular Dysfunction, Left | 2004 |
Why don't we practice evidence-based medicine?
Topics: Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Evidence-Based Medicine; Health Knowledge, Attitudes, Practice; Hospitalization; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Ventricular Dysfunction, Left | 2005 |
Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass grafting.
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Female; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Survival Analysis; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |